Skip to content

AngioDynamics to Disclose Fiscal Year 2026 Q1 Earnings on October 2, 2025

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO), specializing in enhancing vascular system health and expanding cancer treatment options, will release its financial results for the...

AngioDynamics to Announce Financial Results for the First Quarter of Fiscal Year 2026 on October 2,...
AngioDynamics to Announce Financial Results for the First Quarter of Fiscal Year 2026 on October 2, 2025

AngioDynamics to Disclose Fiscal Year 2026 Q1 Earnings on October 2, 2025

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company, will be releasing its first quarter financial results for fiscal year 2026 on October 2, 2025.

The financial report will be released before the market open on the said date. For those who wish to hear the details firsthand, the company has provided a couple of options. Domestic callers can dial 1-844-512-2921, while international callers can use +1-412-317-6671. The passcode to access the call is 13755707.

Participants are asked to dial in at 7:55 am ET on October 2, 2025. The conference call will be accompanied by the leadership team of AngioDynamics, including Senior Vice President and Chief Financial Officer Jeff Kurek.

For those who prefer a digital approach, the conference call will be webcast and can be accessed from the "Investors" section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. A recording of the call will be available until October 09, 2025, at 11:59 PM ET.

AngioDynamics' innovative technologies and devices are selected by skilled physicians in growing healthcare markets. The company treats unmet patient needs, expanding cancer treatment options and improving patient quality of life.

For more information about AngioDynamics, visit www.angiodynamics.com. The news was provided by QuoteMedia, and further details can be found at https://www.businesswire.com/news/home/20250918709095/en/.

The management team will host a conference call at 8:00 am ET on October 2, 2025, to discuss the results. Stephen Trowbridge, the Executive Vice President and CFO of AngioDynamics, Inc., can be reached at (518) 795-1408 for any queries.

Stay tuned for more updates from AngioDynamics as they continue to make strides in the medical technology industry.

Read also:

Latest